# Seoul Pharma completes relocation to expanded Osong plant

Seoul Pharmaceutical completed the relocation of its facilities from Siheung to the expanded Osong plant, enabling integrated production of all dosage forms starting July 2017.

- Type: Expansion
- Announced: 2017-07-01
- Where: Osong, South Korea, South Korea
- Starts operating: Jul 2017
- Status: completed
- Products: orally disintegrating films (ODF), tablets, capsules, granules
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Seoul Pharmaceutical](https://endata.com/companies/25853.md)

## Sources

- [medipharmnews.com](https://www.medipharmnews.com/news/articleView.html?idxno=90336), 2017-07-26: "서울제약은 그 동안 오송공장에서 ODF 제품을, 기존 시화공장에서는 정제•캡슐제•과립제 제품 등을 생산해왔습니다. 하지만 지난해 12월 시화공장 시설을 오송으로 이전한 뒤 시험 생산을 거쳐 올해 7월부터 모든 제형을 통합적으로 생산하게 됐습니다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.